Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 39 (HNRNPA1P39) is a processed pseudogene and a non-protein-coding sequence related to the parent HNRNPA1 gene. Pseudogenes like HNRNPA1P39 do not encode functional proteins due to accumulated mutations. While some pseudogenes have emerging regulatory roles in gene expression by acting as competitive endogenous RNAs or as sources of regulatory noncoding RNAs, there is currently no specific functional or disease association described for HNRNPA1P39 itself in available genomic databases or scientific literature. Key context: - Pseudogenes, by definition, lack the ability to encode a functional product due to mutations or truncations. - The parental protein (hnRNPA1) *is* an RNA-binding protein with important roles in mRNA splicing, gene expression, and is implicated in neurodegenerative diseases and cancer. However, these functions are *not* attributable to HNRNPA1P39. - Current gene and protein databases (GeneCards, BioGPS, Merck Millipore) confirm HNRNPA1P39 is annotated as a pseudogene only, with no demonstrated protein product or therapeutic relevance. In summary: HNRNPA1P39 is not a canonical therapeutic drug target, has no direct biological or clinical function established, and may be listed in research databases for genomic and regulatory studies rather than target identification or drug development.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 39 (HNRNPA1P39).